Elekta Synergy 선형가속기를 이용한 입체적세기조절회전방사선치료(VMAT) 정도관리
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 심수정 | - |
dc.contributor.author | 심장보 | - |
dc.contributor.author | 이상훈 | - |
dc.contributor.author | 민철기 | - |
dc.contributor.author | 조광환 | - |
dc.contributor.author | 신동오 | - |
dc.contributor.author | 최진호 | - |
dc.contributor.author | 박성일 | - |
dc.contributor.author | 조삼주 | - |
dc.date.available | 2020-02-29T08:47:08Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2012-03 | - |
dc.identifier.issn | 2508-4445 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/17291 | - |
dc.description.abstract | For applying the quality assurance (QA) of volumetric modulated arc therapy (VMAT) introduced in Eulji Hospital,we classify it into three different QA steps, treatment planning QA, pretreatment delivering QA, and treatment verifying QA. These steps are based on the existing intensity modulated radiation therapy (IMRT) QA that is currently used in our hospital. In each QA step, the evaluated items that are from QA program are configured and documented. In this study, QA program is not only applied to actual patient treatment, but also evaluated to establish a reference of clinical acceptance in pretreatment delivering QA. As a result, the confidence limits (CLs) in the measurements for the high-dose and low-dose regions are similar to the conventional IMRT level,and the clinical acceptance references in our hospital are determined to be 3 to 5% for the high-dose and the low-dose regions, respectively. Due to the characteristics of VMAT, evaluation of the intensity map was carried out using an ArcCheck device that was able to measure the intensity map in all directions, 360o. With a couple of dosimetric devices, the gamma index was evaluated and analyzed. The results were similar to the result of individual intensity maps in IMRT. Mapcheck, which is a 2-dimensional (2D) array device, was used to display the isodose distributions and gave very excellent local CL results. Thus, in our hospital, the acceptance references used in practical clinical application for the intensity maps of 360o directions and the coronal isodose distributions were determined to be 93% and 95%, respectively. To reduce arbitrary uncertainties and system errors, we had to evaluate the local CLs by using a phantom and to cooperate with multiple organizations to participate in this evaluation. In addition, we had to evaluate the local CLs by dividing them into different sections about the patient treatment points in practical clinics. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 한국의학물리학회 | - |
dc.relation.isPartOf | 의학물리 | - |
dc.title | Elekta Synergy 선형가속기를 이용한 입체적세기조절회전방사선치료(VMAT) 정도관리 | - |
dc.title.alternative | Quality Assurance of Volumetric Modulated Arc Therapy for Elekta Synergy | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 2 | - |
dc.identifier.bibliographicCitation | 의학물리, v.23, no.1, pp.33 - 41 | - |
dc.identifier.kciid | ART001683078 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 41 | - |
dc.citation.startPage | 33 | - |
dc.citation.title | 의학물리 | - |
dc.citation.volume | 23 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | 최진호 | - |
dc.subject.keywordAuthor | 치료검증 정도관리 | - |
dc.subject.keywordAuthor | 세기조절방사선치료 | - |
dc.subject.keywordAuthor | 입체적세기조절회전방사선치료 | - |
dc.subject.keywordAuthor | 신뢰수준 | - |
dc.subject.keywordAuthor | 정도관리 절차서 | - |
dc.subject.keywordAuthor | Treatment verifying QA | - |
dc.subject.keywordAuthor | IMRT | - |
dc.subject.keywordAuthor | VMAT | - |
dc.subject.keywordAuthor | Confidence limit | - |
dc.subject.keywordAuthor | QA protocol | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.